IcoCell− Chassis for Enhanced Mammalian Cell Line Development and Engineering

Objective

The opportunity to focus on the production of biopharmaceuticals is often taken from SMEs since huge amount of resources is required for the development of high-producer cell lines. We envision that our parental cell factories will increase the efficiency of cell line engineering and will effectively reduce the time-to-market for mammalian cell-based products. It allows SMEs to leverage their traditional strengths of adaptability and creativity, and to develop novel products for biotechnology industries.

Fields of science

• natural sciences › biological sciences › biochemistry › biomolecules › proteins

Programme(s)

• H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Topic(s)

• BIOTEC-5a-2014-1 - SME boosting biotechnology-based industrial processes driving competitiveness and sustainability

Call for proposal

H2020-SMEINST-1-2014
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

ICOSAGEN CELL FACTORY OU

Address

Eerika Tee 1
61713 Kambja Vald
Estonia

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

EU contribution

€ 50 000